Ticker brief
KAPA
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
5
crowd 14d
+0.5σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-06 → 2026-10-07 · now +0.00 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BiopharmIQ | B | · | 2 | -0.55 |
| @BioStocks | C | -1.77 | 1 | +0.60 |
| @aljehani | C | -1.16 | 1 | +0.60 |
| @smith_will86715 | C | -3.74 | 1 | +0.00 |
| @OzmosiHealth | C | · | 1 | +0.00 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-07 | @OzmosiHealth | +0.00 | Reports Phase 2 ENV-105 results were presented on 2026-10-06. | · | tweet ↗ |
| 2026-10-06 | @BiopharmIQ | -0.55 | Reports sharp opening declines tied to a Phase 3 update, interim data and an equity raise. | · | tweet ↗ |
| 2026-10-06 | @BiopharmIQ | -0.55 | Biotech mover list quantifies the largest negative opening reactions and their associated catalysts. | · | tweet ↗ |
| 2026-10-06 | @smith_will86715 | +0.00 | Bullishly compares OLB's move with KAPA. | · | tweet ↗ |
| 2026-10-06 | @aljehani | +0.60 | Phase 2 ENV-105 data showed 17.7 months median progression-free survival versus two months. | · | tweet ↗ |
| 2026-10-06 | @BioStocks | +0.60 | KAPA reported positive statistically significant interim Phase 2 efficacy data. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.